Randomized Clinical Trial: Oral Health Package Law and Fluor Varnish Impact on Schoolchildren in Merida, Mexico
Launched by ANAHUAC MAYAB UNIVERSITY · Jul 18, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the "Randomized Clinical Trial: Oral Health Package Law and Fluor Varnish Impact on Schoolchildren in Merida, Mexico," is studying how a daily school brushing program and the use of fluoride varnish can improve oral health in children aged 6 to 8 years old. The focus is on preventing problems like cavities and gum disease among schoolchildren in public elementary schools in Mérida, Mexico. The study will follow participants for two years, from 2023 to 2025, to see how these methods affect their dental health.
To participate, children need to be between 6 and 8 years old, currently enrolled in the first three grades of elementary school, and in good general health. Parents or caregivers must also be willing to provide consent for their child to join the study. However, children with certain health issues, allergies to oral care products, or those currently undergoing treatments like chemotherapy will not be eligible. Participants can expect regular check-ups and guidance on oral health during the trial, helping them learn good brushing habits while also receiving fluoride treatment to strengthen their teeth.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Men and women, between 6-8 years of age;
- • 2. Children enrolled in first, second and third grade of primary education
- • 3. Availability during the duration of the study;
- • 4. Good general health (absence of any condition that, in the opinion of the Principal Investigator, could constitute a risk to the subject while participating in the study.
- • 5 Examples include heart problems, valve/hip replacements, etc.);
- • 6 Willingness to provide information related to his medical history;
- • 7 Informed consent form signed by the caregiver;
- • 8 Informed consent signed by the child
- Exclusion Criteria:
- * 1 Subjects must not have any of the following:
- • 2 The caregiver is unwilling to sign the informed consent form
- • 3 Subject participating in any other clinical study;
- • 4. Subject allergic to oral care products, consumer personal care products or their ingredients;
- • 5. Subjects with orthodontic bands, removable partial dentures, tumors of the hard parts or soft tissue of the oral cavity, or advanced periodontal disease
- • 6. Continued use of medications known to affect gingival tissues (ie, calcium channel blockers, phenytoin, cyclosporine);
- • 7. Subject is currently receiving chemotherapy
- • 8. Subject has leukemia
About Anahuac Mayab University
Anahuac Mayab University is a distinguished academic institution dedicated to advancing research and education in the biomedical field. With a commitment to excellence, the university fosters innovative clinical trials aimed at improving healthcare outcomes and addressing pressing medical challenges. Leveraging a collaborative approach that integrates multidisciplinary expertise, Anahuac Mayab University emphasizes ethical research practices and strives to enhance patient care through evidence-based findings. Its focus on rigorous scientific inquiry positions the university as a vital contributor to the advancement of clinical knowledge and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mérida, Yucatan, Mexico
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported